Previous Article |
Table of Contents
| Next Article
* Department of Pharmacology, Cornell University Medical College,
New York, NY 10021; and
Edited by Ronald M. Evans, Salk Institute for Biological Studies,
San Diego, CA, and approved July 7, 1997
(received for review June 2, 1997)
Murine 3T3 cells arrest in a quiescent, nondividing state when
transferred into medium containing little or no serum. Within the first
day after transfer, fibroblasts can be activated to proliferate by
platelet-derived growth factor (PDGF) alone; cells starved longer than
1 day, however, are activated only by serum. We demonstrate that
endogenous vitamin A (retinol) or retinol supplied by serum
prevents cell death and that retinol, in combination with PDGF, can
fully replace serum in activating cells starved longer than 1 day. The
physiological retinol derivative
14-hydroxy-4,14-retro-retinol, but not retinoic acid,
can replace retinol in rescuing or activating 3T3 cells.
Anhydroretinol, another physiological retinol metabolite that acts as a
competitive antagonist of retinol, blocks cell activation by serum,
indicating that retinol is a necessary component of serum. It
previously has been proposed that activation of 3T3 cells requires two
factors in serum, an activation factor shown to be PDGF and an
unidentified survival factor. We report that retinol is the survival
factor in serum.
Mammalian sera contain 1-2 µM vitamin A (retinol) (1). Retinol
is metabolized by cells to physiological derivatives (2), including
11-cis-retinal involved in vision (3), retinoic acids that
induce differentiation in a variety of systems (4), and three signaling
molecules, 14-hydroxy-4,14-retro-retinol (14-HRR) (5, 6),
anhydroretinol (AR) (7-9), and 13,14-dihydroxyretinol (DHR) (10). Of
the retinoids, 14-HRR, DHR, and retinol, at least one is required in T
lymphocyte activation (6, 10, 11) and for the growth of B
lymphoblastoid (5, 6, 10, 12, 13) and HL-60 (8) cells when these cells
are cultured in serum-free medium. AR competitively inhibits the
growth-supportive effects of 14-HRR, DHR, or retinol (7-10). The
enzyme, retinol dehydratase, which converts retinol to AR in the moth
Spodoptera frugiperda recently has been purified, cloned,
and expressed (14).
When deprived of serum, NIH 3T3 cells arrest in a nondividing,
quiescent state (15, 16). Proliferation of cells starved for 1 day is
reportedly stimulated by platelet-derived growth factor (PDGF) (17),
fibroblast growth factor (18), epidermal growth factor (EGF) (19), and
phorbol ester (20); however, cells starved longer can be activated only
by serum (21). We show in this study that retinol in serum and its
intracellular derivative, 14-HRR, play an essential role in 3T3 cell
activation. Whereas PDGF and EGF are activation factors and initiate
the cell cycle, retinol and 14-HRR ensure cell cycle progression by
preventing cell death.
NIH 3T3 cells (American Type Culture
Collection) plated in 96-well microtiter plates in 100 µl/well of
DMEM containing 10% calf serum (Colorado Serum, Denver) were grown to
almost confluency, then were arrested by starvation in 150 µl/well
of DMEM containing 0.5% calf serum. Cells were starved for 2 days
before the assay unless mentioned otherwise. Resting cells were treated
with assay reagents in 200 µl/well of RPMI medium 1640 containing
0.1% BSA (Sigma) and labeled with 1 µCi [3H]thymidine
(6.7 Ci/mmol, DuPont/NEN) for given durations. In Fig.
1, cells were labeled with
[3H]thymidine for 24 hr starting from the activation
event. In Fig. 2, cells were
pulsed with thymidine for 2 hr at different time points after
activation. In Fig. 3, cells were
labeled with [3H]thymidine for 14 hr starting 10 hr
postactivation. All culture media were supplemented with 2 mM glutamine
and 100 units/ml of penicillin/streptomycin. The data represent the
mean of triplicates. 14-HRR (6) and AR (22) were synthesized following
published procedures; PDGF and EGF were purchased from Boehringer
Mannheim; retinol, retinoic acid, and dexamethasone from Sigma; and
ceramides and sphingosines from Calbiochem.
NIH 3T3 cells were plated and starved
for 2 days as described above. Cells were treated with PDGF alone or
PDGF plus retinol. After given time points cells were pulsed with WST-1
(5% vol/vol, Boehringer Mannheim) for 2 hr, and color development
(A450nm-A650nm) was quantified using a 96-well
reader (Molecular Dynamics).
NIH 3T3
cells were grown in 9 ml of DMEM containing 10% calf serum in 10-cm
tissue culture dishes. At 30-40% confluency, 30 µCi
[3H]retinol (DuPont/NEN) was added, and cells were
grown for an additional 48 hr to almost confluency. Then cells were
starved in DMEM containing 0.5% calf serum. At given time points cells were delipidated (23), and the organic extracts were analyzed as
described (5).
Cell activation was quantified by measuring
[3H]thymidine incorporation in serum-starved,
growth-arrested NIH 3T3 cells, which then were treated with serum,
PDGF, retinol, or PDGF and retinol (PDGF/retinol) in assay medium
(RPMI medium 1640 containing 0.1% BSA) (Fig. 1A).
After 1 day of serum starvation, activation by PDGF alone reached
approximately 50% of the level of serum activation. However, after
serum starvation for 2 and 3 days, cells failed to be activated by PDGF
alone due to cell death and were activated only by serum. We tested
whether retinol was a fibroblast survival factor for the following
reasons: (i) retinol is a component of serum (1);
(ii) the intracellular retinol level decreases during starvation (8); and (iii) retinol supports the growth of B lymphoblastoid cells cultured in serum-free medium (5, 6, 12, 13). We
found that addition of retinol indeed prevented cell death due to serum
deprivation. Retinol by itself was not mitogenic, but in combination
with PDGF it fully replaced serum in activating starved 3T3 cells
regardless of the duration of serum starvation (Fig.
1A). Similar to PDGF, EGF activation of NIH 3T3
cells was also dependent on retinol, and retinol was effective at
submicromolar concentrations (Fig. 1B).
We measured the endogenous retinol level in NIH 3T3 cells
during serum starvation (Fig. 1C). After 24 hr of
starvation, the intracellular retinol concentration decreased to about
10% of its initial level and to about 5% after 48 hr. The depletion
of intracellular retinol mirrors the decreased viability after PDGF activation.
Other lipid molecules also were tested to determine whether they
synergized with PDGF in activating starved 3T3 cells (Fig. 2). Only
14-HRR was able to replace retinol. In 3T3 cells, retinol is
metabolized to 14-HRR (data not shown); therefore, 14-HRR may be the
physiological mediator of retinol's action. Retinoic acid showed a
negative effect at the concentrations tested, and ceramides, sphingosine 1-phosphate, and sphingosine at their optimum
concentrations gave 10-20% of the activity shown by retinol or
14-HRR. The glucocorticoid dexamethasone was inactive.
The time required for serum-starved cells to enter S
phase of the cell cycle was identical whether the cells were activated by 20% calf serum or by PDGF/retinol (Fig. 3A). In both
cases the cells required 12 hr from the start of activation to enter S phase and underwent more than one cell cycle. However,
PDGF and retinol have distinct effects on cells entering the cell
cycle. When added at different times, delayed addition of PDGF
postponed S-phase entry but had no effect on the total
number of activated cells (Fig. 3B); on the other hand,
delayed addition of retinol decreased the total number of activated
cells but had no effect on the time required for S-phase
entry (Fig. 3C). These data imply PDGF acts as an activator
that initiates the cell cycle, whereas retinol acts as a survival
factor that ensures cell cycle progression by preventing cell death.
Being a competitive antagonist of retinol (7-9), AR provides a
convenient means to determine whether retinol is required for 3T3 cell
activation. AR competitively inhibited cell activation by
PDGF/retinol in serum-starved 3T3 cells (Fig.
4A). AR also inhibited
cell activation by serum in these cells (Fig. 4B).
Furthermore, the inhibition by AR could be reversed by addition of
retinol (Fig. 4 A and B) or 14-HRR (data not
shown), strongly indicating that retinol supplied by serum is a
requirement for 3T3 cell activation.
To determine whether retinol is required as a survival factor
regardless of the activation status of NIH 3T3 cells, we used WST-1, a
dye that monitors mitochondrial activity, to quantify the number of
viable cells. In serum-starved resting cultures after treatment with
assay medium alone or with PDGF the number of viable cells steadily
decreased over time, and addition of retinol prevented cell death (Fig.
5 A and B).
The presence of PDGF did not rescue cells from death; however, cell
death was delayed for about 4 hr (Fig. 5B). In both cases
the number of viable cells was dependent on the concentration of
retinol, and the dose-response curve was not shifted by PDGF (Fig.
5C).
We have demonstrated that retinol is necessary, and in
combination with PDGF, is also sufficient to fully replace serum in activating serum-starved resting 3T3 cells. This result extends our
knowledge of retinol dependency to fibroblasts and presents an example
of full activation of 3T3 cells in defined medium. The 3T3 cell system
distinguishes between activation and survival factors. PDGF is a major
activation factor in serum. The existence of a survival factor in serum
was first proposed 25 years ago (24, 25). The ability of retinol to
sustain viability of 3T3 cells during serum starvation, regardless of
the activation status, strongly suggests that retinol is the survival
factor in serum. Earlier studies showed that retinol was essential for
T lymphocyte activation (11) and for the growth of B lymphoblastoid (5, 6, 12, 13) and HL-60 (8) cells cultured in serum-free medium. We
postulate that retinol's survival effect also may contribute to the
growth-supportive activity observed in T, B, and HL-60 cells.
Together with the published data on T and B lymphocytes (5, 6, 10-13)
and promyelocytic cells (8), the present study suggests the existence
of an intracellular signaling pathway dependent on vitamin A distinct
from that of retinoic acid mediated by the nuclear receptors RAR and
RXR (26, 27). In a retinol-dependent thymoma cell line AR-induced cell
death can be prevented by the tyrosine kinase inhibitor, herbimycin A
(28). The same herbimycin effect also was observed in 3T3 cells treated
with AR (data not shown), implying that the retinol/14-HRR/AR
signaling pathway in both lymphocytes and fibroblasts involves the
regulation of tyrosine phosphorylation. Mammalian sera contain 1-2
µM retinol (1), tissues such as liver and lung contain micromolar
concentrations of AR (data not shown); therefore, in these cells the
balance between retinol and AR may determine the survival or death of cells.
Proc. Natl. Acad. Sci. USA
Vol. 94,
pp. 10205-10208,
September 1997
Cell Biology
, and
Immunology Program, Sloan-Kettering
Institute, New York, NY 10021
Cell Activation Assays.
Fig. 1.
Retinol is required for activation of NIH 3T3
cells arrested by serum starvation. (A) NIH 3T3 cells
starved in DMEM containing 0.5% calf serum for 1-3 days were treated
with 10% calf serum, 50 ng/ml PDGF, 2 µM retinol (ROL), a
combination of 50 ng/ml PDGF and 2 µM retinol, or assay medium
alone. (B) Dose-dependent activation of 2-day starved cells
by retinol in the presence of PDGF (50 ng/ml) and EGF (50 ng/ml).
(C) Relative intracellular retinol concentration in NIH 3T3
cells starved for the indicated time. Data of activation assays
represent the mean and SDs of triplicate measurements.
[View Larger Version of this Image (15K GIF file)]
Fig. 2.
Effect of different lipophilic molecules on PDGF
activation of 2-day serum-starved cells: 50 ng/ml PDGF, 2 µM
retinol (ROL), 4 µM 14-HRR, 4 µM retinoic acid (RA), 4 µM
dexamethasone (DEX), 5[mu]M sphingosine-1-phosphate (SPP-1) 10 µM
ceramide C-2 (C2), 10 µM ceramide C-6 (C6), and 5 µM sphingosine
(SP). Data of activation assays represent the mean and SDs of
triplicate measurements.
[View Larger Version of this Image (33K GIF file)]
Fig. 3.
PDGF determines entry time into S
phase of cell cycle, and retinol determines number of activated cells.
(A) Cell cycles of 2-day starved NIH 3T3 cells stimulated by
20% calf serum or by a combination of 50 ng/ml PDGF and 2 µM
retinol (ROL). (B) Retinol (2 µM) was added at time 0 hr,
PDGF (50 ng/ml) at time 0, 4, and 6 hr. (C) PDGF (50 ng/ml) was added at time 0 hr, retinol (2 µM) at time 0, 4, and 6 hr. Data represent the mean of triplicate measurements, and SDs
were
15%.
[View Larger Version of this Image (17K GIF file)]
Fig. 4.
AR blocks activation of NIH 3T3 cells by
PDGF/retinol and by serum. (A) Addition of AR (20 µM, 6 µM, 0 µM) to 2-day serum-starved NIH 3T3 cells activated by PDGF
(50 ng/ml) and retinol (0-5 µM). (B) Addition of AR (30 µM, 10 µM, 3 µM) to 2-day serum-starved NIH 3T3 cells activated
by 5% calf serum supplemented with retinol (0-5 µM). Data represent
the mean and SDs of triplicate measurements.
[View Larger Version of this Image (20K GIF file)]
Fig. 5.
Addition of retinol (ROL) prevents cell death.
Time course of cell viability, as measured by WST-1, of 2-day
serum-starved cultures after treatment with retinol (2 µM, 1 µM,
0.5 µM, 0.25 µM, 0 µM) (A) in assay medium alone and
(B) in medium with PDGF (50 ng/ml). Data represent one of
three independent measurements. (C) Dose-dependent
prevention of cell death by retinol (0-10 µM) after 13-hr treatment
in the absence or presence of PDGF (50 ng/ml). Data represent the
mean and SDs of triplicate measurements.
[View Larger Version of this Image (16K GIF file)]
To whom reprint requests should be addressed at:
Department of Pharmacology, Cornell University Medical College, 1300 York Avenue, New York, NY 10021. e-mail:
jobuck{at}mail.med.cornell.edu.
We thank Drs. Ulrich Hämmerling and Lonny Levin and the members of the Buck laboratory for comments on the manuscript. This work was supported by grants from the American Cancer Society (J.B.) and National Institutes of Health (F.D. and J.B.). J.B. is a Pew Scholar in the Biomedical Sciences.
| 1. | Goodman, D. S. (1984) in The Retinoids, eds. Sporn, M. B., Roberts, A. B. & Goodman, D. S. (Academic, New York), pp. 41-48. |
| 2. | Blaner, W. S. & Olson, J. A. (1994) in The Retinoids: Biology, Chemistry, and Medicine, eds. Sporn, M. B., Roberts, A. B. & Goodman, D. S. (Raven, New York), pp. 229-256. |
| 3. |
Wald, G.
(1968)
Science
162,
230-239
|
| 4. | Gudas, L. J., Sporn, M. B. & Roberts, A. B. (1994) in The Retinoids: Biology, Chemistry, and Medicine, eds. Sporn, M. B., Roberts, A. B. & Goodman, D. S. (Raven, New York), pp. 443-520. |
| 5. |
Buck, J., Derguini, F., Levi, E., Nakanishi, K. & Hämmerling, U.
(1991)
Science
254,
1654-1656
|
| 6. | Derguini, F., Nakanishi, K., Hämmerling, U. & Buck, J. (1994) Biochemistry 33, 623-628 [CrossRef][Medline] . |
| 7. |
Buck, J., Grün, F., Derguini, F., Chen, Y., Kimura, S., Noy, N. & Hämmerling, U.
(1993)
J. Exp. Med.
178,
675-680
|
| 8. |
Eppinger, T. M., Buck, J. & Hämmerling, U.
(1993)
J. Exp. Med.
178,
1995-2005
|
| 9. | Derguini, F., Nakanishi, K., Buck, J., Hämmerling, U. & Grün, F. (1994) Angew. Chem. Int. Ed. Engl. 33, 1839-1841 [CrossRef]. |
| 10. |
Derguini, F., Nakanishi, K., Hämmerling, U., Chua, R., Eppinger, T., Levi, E. & Buck, J.
(1995)
J. Biol. Chem.
270,
18875-18880
|
| 11. |
Garbe, A., Buck, J. & Hämmerling, U.
(1992)
J. Exp. Med.
176,
109-117
|
| 12. |
Buck, J., Ritter, G., Dannecker, L., Katta, Y., Cohen, S. L., Chait, B. T. & Hämmerling, U.
(1990)
J. Exp. Med.
171,
1613-1624
|
| 13. |
Buck, J., Myc, A., Garbe, A. & Cathomas, G.
(1991)
J. Cell Biol.
115,
851-859
|
| 14. |
Grün, F., Noy, N., Hämmerling, U. & Buck, J.
(1996)
J. Biol. Chem.
271,
16135-16138
|
| 15. | Todaro, G. J., Lazar, G. K. & Green, H. (1965) J. Cell. Comp. Physiol. 66, 325-334 [CrossRef][ISI][Medline] . |
| 16. |
Holley, R. W. & Kiernan, J. A.
(1968)
Proc. Natl. Acad. Sci. USA
60,
300-304
|
| 17. |
Pledger, W. J., Hart, A. A., Locatell, K. L. & Scher, C. D.
(1981)
Proc. Natl. Acad. Sci. USA
78,
4358-4362
|
| 18. | Gospodarowicz, D. (1974) Nature (London) 249, 123-127 [CrossRef][Medline] . |
| 19. | Leof, E. B., Van Wyk, J. J., O'Keefe, E. J. & Pledger, W. J. (1983) Exp. Cell Res. 147, 202-208 [CrossRef][ISI][Medline] . |
| 20. | Rozengurt, E., Rodriguez-Pena, A., Combs, M. & Sinnett-Smith, J. (1984) Proc. Natl. Acad. Sci. USA 181, 5748-5752 . |
| 21. |
Brooks, R. F., Howard, M., Leake, D. S. & Riddle, P. N.
(1990)
J. Cell Sci.
97,
71-78
|
| 22. |
Embree, N. D.
(1939)
J. Biol. Chem.
128,
187-198
|
| 23. |
McLean, S. W., Ruddel, M. E., Gross, E. G., De Giovanna, J. J. & Peck, G. L.
(1982)
Clin. Chem.
28,
693-696
|
| 24. |
Paul, D., Lipton, A. & Klinger, I.
(1971)
Proc. Natl. Acad. Sci. USA
68,
645-648
|
| 25. | Lipton, A., Paul, D., Henahan, M., Klinger, I. & Holly, R. W. (1972) Exp. Cell Res. 74, 466-470 [CrossRef][ISI][Medline] . |
| 26. | Mangelsdorf, D. J., Umesono, K. & Evans, R. (1994) in The Retinoids: Biology, Chemistry, and Medicine, eds. Sporn, M. B., Roberts, A. B. & Goodman, D. S. (Raven, New York), pp. 319-349. |
| 27. | Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. & Evans, R. M. (1995) Cell 83, 835-841 [CrossRef][ISI][Medline] . |
| 28. |
O'Connell, M. J., Chua, R., Hoyos, B., Buck, J., Chen, Y., Derguini, F. & Hämmerling, U.
(1996)
J. Exp. Med.
184,
549-555
|
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
B. Hoyos, A. Imam, I. Korichneva, E. Levi, R. Chua, and U. Hammerling Activation of c-Raf Kinase by Ultraviolet Light. REGULATION BY RETINOIDS J. Biol. Chem., June 21, 2002; 277(26): 23949 - 23957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hind, J. Corcoran, and M. Maden Alveolar Proliferation, Retinoid Synthesizing Enzymes, and Endogenous Retinoids in the Postnatal Mouse Lung . Different Roles for Aldh-1 and Raldh-2 Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 67 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
, , , , , , , and The Cysteine-rich Regions of the Regulatory Domains of Raf and Protein Kinase C as Retinoid J. Exp. Med., September 18, 2000; 192(6): 835 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen and J. Buck Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 807 - 812. [Abstract] [Full Text] |
||||
![]() |
W.A. Kues, M. Anger, J.W. Carnwath, D. Paul, J. Motlik, and H. Niemann Cell Cycle Synchronization of Porcine Fetal Fibroblasts: Effects of Serum Deprivation and Reversible Cell Cycle Inhibitors Biol Reprod, February 1, 2000; 62(2): 412 - 419. [Abstract] [Full Text] |
||||
![]() |
Y. Chen, J. Buck, and F. Derguini Anhydroretinol Induces Oxidative Stress and Cell Death Cancer Res., August 1, 1999; 59(16): 3985 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Korichneva and U Hammerling F-actin as a functional target for retro-retinoids: a potential role in anhydroretinol-triggered cell death J. Cell Sci., January 8, 1999; 112(15): 2521 - 2528. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||